A Study to Evaluate the Potential for Interpersonal Transfer of Testosterone Following Single Dose Application

Completed

• Conditions: Hypogonadism

• Registration Number: NCT01172366
• Lead Sponsor: Acrux DDS Pty Ltd

Brief Summary

The hypotheses for this study is that there is no transfer of testosterone from male (donor) subjects to female (recipient) subjects when contact is made 2 hours post application of 2% Testosterone MD-Lotion® if the donor has a covered application area with a T-shirt.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-07-28
• Study First Submitted QC: 2010-07-28
• Study First Posted: 2010-07-29
• Status Verified: 2010-08
• Study Start: 2010-08
• Primary Completion: 2010-09
• Study Completion: 2010-09
• Last Update Submitted: 2010-09-02
• Last Update Posted: 2010-09-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pharmacokinetics	72 hours total	Single dose pharmacokinetic parameters (AUC0-24, AUC0-72, Cmin, Cmax, and tmax) are to be reported for total testosterone, free testosterone and DHT.

Trial Locations

Locations (1)

QPharm; 🇦🇺 Brisbane, Queensland, Australia